Text Size

Hemofiltration for Contrast-Induced Nephropathy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Nara Medical University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Nara Medical University
ClinicalTrials.gov Identifier:
NCT00158080
First received: September 7, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
  Purpose

Contrast-induced acute renal failure can be prevented with hemofiltration which is performed during cardiac catheterization


Condition Intervention
Chronic Kidney Disease
Cardiac Catheterization
 Procedure: hemofiltration

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Prevention of Contrast-Induced Nephropathy by Real-Time Hemofiltration

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Nara Medical University:

Primary Outcome Measures:
  • Prevention of contrast-induced acute renal failure, Elevation of serum creatinine

Secondary Outcome Measures:
  • Need for hemodialysis

Estimated Enrollment: 100
  Eligibility

Ages Eligible for Study:   20 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with serum creatinine>2.0mg/dl and/or GFR<50ml/min

Exclusion Criteria:

  • Emergent cardiac catheterization
  • Patients on chronic dialysis
  • Patients with HYHA>III heart failure
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00158080

Contacts
Contact: Koji Harada, MD +81-744-22-3051 ext 3411 kzharada@naramed-u.ac.jp

Locations
Japan
First Dept of InternalMedicine, Nara Medical University Recruiting
Kashihara, Nara, Japan, 634-8522
Contact: Koji Harada, MD     +81-744-22-3051 ext 3411     kzharada@naramed-u.ac.jp    
Sponsors and Collaborators
Nara Medical University
Investigators
Study Director: Yoshihiko Saito, MD, PhD Nara Medical University
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00158080     History of Changes
Other Study ID Numbers: K0001
Study First Received: September 7, 2005
Last Updated: September 7, 2005
Health Authority: Japan: Ministry of Health, Labor and Welfare

Additional relevant MeSH terms:
Kidney Diseases
Renal Insufficiency, Chronic
Kidney Failure, Chronic
Urologic Diseases
Renal Insufficiency

ClinicalTrials.gov processed this record on May 22, 2013